July 28, 2015 Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease
July 6, 2015 Moerae Matrix Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer
August 05, 2014 Moerae Matrix Initiates Phase 1 Clinical Trial of MMI-0100